Tg Therapeutics (TGTX) Operating Margin Growth (5y) (2022 - 2026)

Tg Therapeutics (TGTX) Operating Margin Growth (5y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Tg Therapeutics 8.08 Bn 8.00 Bn 171.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.13 Mn
Dec 31, 2025 22.84 Mn
Sep 30, 2025 22.56 Mn
Jun 30, 2025 13.38 Mn
Mar 31, 2025 13.22 Mn
Dec 31, 2024 9.99 Mn
Sep 30, 2024 16.02 Mn
Jun 30, 2024 9.35 Mn
Mar 31, 2024 9.13 Mn
Dec 31, 2023 14.25 Mn
Sep 30, 2023 9.04 Mn
Jun 30, 2023 -11.70 Mn
Mar 31, 2023 10.89 Mn
Dec 31, 2022 -1.53 Mn
Sep 30, 2022 4.59 Mn
Jun 30, 2022 6.82 Mn